ATE269974T1 - Identifizierung und charakterisierung von interagierenden molekülen mittels automatisierter interagierender paarung - Google Patents

Identifizierung und charakterisierung von interagierenden molekülen mittels automatisierter interagierender paarung

Info

Publication number
ATE269974T1
ATE269974T1 AT98965193T AT98965193T ATE269974T1 AT E269974 T1 ATE269974 T1 AT E269974T1 AT 98965193 T AT98965193 T AT 98965193T AT 98965193 T AT98965193 T AT 98965193T AT E269974 T1 ATE269974 T1 AT E269974T1
Authority
AT
Austria
Prior art keywords
interacting
identification
characterization
interacting molecules
automated
Prior art date
Application number
AT98965193T
Other languages
English (en)
Inventor
Erich Wanker
David Bancroft
Hans Lehrach
Niels Wedemeyer
Elmar Maier
Sebastian Meier-Ewert
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of ATE269974T1 publication Critical patent/ATE269974T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Vending Machines For Individual Products (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98965193T 1997-11-27 1998-11-27 Identifizierung und charakterisierung von interagierenden molekülen mittels automatisierter interagierender paarung ATE269974T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP97120879 1997-11-27
EP97120867 1997-11-27
EP97120880 1997-11-27
PCT/EP1998/007657 WO1999028745A1 (en) 1997-11-27 1998-11-27 Identification and characterization of interacting molecules by automated interaction mating

Publications (1)

Publication Number Publication Date
ATE269974T1 true ATE269974T1 (de) 2004-07-15

Family

ID=27238345

Family Applications (2)

Application Number Title Priority Date Filing Date
AT98965192T ATE262178T1 (de) 1997-11-27 1998-11-27 Identifizierung und charakterisierung von interagierenden molekülen
AT98965193T ATE269974T1 (de) 1997-11-27 1998-11-27 Identifizierung und charakterisierung von interagierenden molekülen mittels automatisierter interagierender paarung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT98965192T ATE262178T1 (de) 1997-11-27 1998-11-27 Identifizierung und charakterisierung von interagierenden molekülen

Country Status (10)

Country Link
US (1) US6664048B1 (de)
EP (3) EP1036324B1 (de)
JP (3) JP2001525186A (de)
AT (2) ATE262178T1 (de)
AU (3) AU1757599A (de)
CA (3) CA2311927A1 (de)
DE (2) DE69822510T2 (de)
GB (1) GB2338711B (de)
IL (3) IL136393A0 (de)
WO (3) WO1999028744A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029847B2 (en) 2000-05-16 2006-04-18 Massachusetts Institute Of Technology Methods and compositions for interaction trap assays
WO2001088197A2 (en) 2000-05-16 2001-11-22 Massachusetts Institute Of Technology Methods and compositions for interaction trap assays
ES2284655T3 (es) * 2000-06-13 2007-11-16 Glaxo Group Limited Seleccion de alto rendimiento de compuestos para actividad biologica.
ATE371749T1 (de) * 2000-06-23 2007-09-15 Domantis Ltd Matrix-screening-verfahren
JP4024994B2 (ja) 2000-06-30 2007-12-19 株式会社東芝 半導体発光素子
WO2002004628A2 (en) * 2000-07-06 2002-01-17 Genvec, Inc. Method of identifying a binding partner of a gene product
EP1299950B1 (de) 2000-07-13 2008-05-21 CT-Concept Technologie AG Verfahren und vorrichtung zur zustandsabhängigen regelung des transienten verhaltens von leistungshalbleiterschaltern
GB2384309B8 (en) * 2000-10-13 2016-03-02 Irm Llc High throughput processing system and method of using
WO2002070662A2 (en) 2001-03-02 2002-09-12 Gpc Biotech Ag Three hybrid assay system
EP1243327A1 (de) * 2001-03-19 2002-09-25 BioChip Technologies GmbH Oberfläche mit einem Muster aus Zellen und Verfahren zu deren Herstellung
US7219016B2 (en) * 2001-04-20 2007-05-15 Yale University Systems and methods for automated analysis of cells and tissues
WO2002103608A2 (en) * 2001-06-14 2002-12-27 Ramot University Authority For Applied Research & Industrial Development Ltd. Method of expanding a biological network
DE10141522C1 (de) * 2001-08-24 2003-03-06 Siemens Ag Verfahren zur Herstellung einer Leuchtstoffschicht
US20020094519A1 (en) * 2002-03-07 2002-07-18 Agencourt Bioscience Corporation Detection of protein interactions
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
US20050074780A1 (en) * 2003-10-01 2005-04-07 Bryhan Marie D. Device for analyzing slides
WO2006040154A2 (en) * 2004-10-14 2006-04-20 Dublin City University Prokaryotic two hybrid system
US7988872B2 (en) 2005-10-11 2011-08-02 Applied Materials, Inc. Method of operating a capacitively coupled plasma reactor with dual temperature control loops
US8157951B2 (en) 2005-10-11 2012-04-17 Applied Materials, Inc. Capacitively coupled plasma reactor having very agile wafer temperature control
US8092638B2 (en) 2005-10-11 2012-01-10 Applied Materials Inc. Capacitively coupled plasma reactor having a cooled/heated wafer support with uniform temperature distribution
US8034180B2 (en) 2005-10-11 2011-10-11 Applied Materials, Inc. Method of cooling a wafer support at a uniform temperature in a capacitively coupled plasma reactor
US8021521B2 (en) 2005-10-20 2011-09-20 Applied Materials, Inc. Method for agile workpiece temperature control in a plasma reactor using a thermal model
US7932030B2 (en) * 2007-04-05 2011-04-26 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College System for pulling out regulatory elements using yeast
AU2008298603B2 (en) 2007-09-14 2015-04-30 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
EP3336225B1 (de) 2010-07-16 2020-02-19 Adimab, LLC Antikörperbibliotheken
WO2018011422A1 (en) * 2016-07-15 2018-01-18 Danmarks Tekniske Universitet Plating cells and corresponding picking colonies
WO2018213343A1 (en) * 2017-05-16 2018-11-22 The Regents Of The University Of California Fluorescence detection in yeast colonies
WO2021092323A1 (en) * 2019-11-06 2021-05-14 General Automation Lab Technologies Inc. Method for picking biological sample

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5789184A (en) 1993-03-31 1998-08-04 Cadus Pharmaceutical Corporation Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US5503977A (en) 1994-04-22 1996-04-02 California Institute Of Technology Split ubiquitin protein sensor
ATE352638T1 (de) * 1995-04-11 2007-02-15 Gen Hospital Corp REVERSE ßTWO-HYBRIDß-SYSTEME
US5569588A (en) * 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
EP0790304A1 (de) * 1995-12-21 1997-08-20 AMERSHAM INTERNATIONAL plc Auf Nachweismethoden bezogene Verbesserungen
US6083693A (en) * 1996-06-14 2000-07-04 Curagen Corporation Identification and comparison of protein-protein interactions that occur in populations
AU4159697A (en) * 1996-08-23 1998-03-06 President And Fellows Of Harvard College Interaction trap assay, reagents and uses thereof

Also Published As

Publication number Publication date
IL136394A0 (en) 2001-06-14
JP2002508517A (ja) 2002-03-19
EP1042670B1 (de) 2004-03-17
EP1042670A1 (de) 2000-10-11
AU760908B2 (en) 2003-05-22
DE69822510D1 (de) 2004-04-22
AU2050499A (en) 1999-06-16
EP1036329A1 (de) 2000-09-20
GB9923293D0 (en) 1999-12-08
IL136393A0 (en) 2001-06-14
JP2002507386A (ja) 2002-03-12
WO1999028744A1 (en) 1999-06-10
US6664048B1 (en) 2003-12-16
AU1757599A (en) 1999-07-05
CA2311927A1 (en) 1999-06-10
DE69824757D1 (de) 2004-07-29
EP1036324B1 (de) 2004-06-23
EP1036324A1 (de) 2000-09-20
GB2338711A (en) 1999-12-29
AU2050599A (en) 1999-06-16
DE69824757T2 (de) 2005-10-20
GB2338711A8 (en) 2000-01-26
AU762954B2 (en) 2003-07-10
ATE262178T1 (de) 2004-04-15
WO1999031509A1 (en) 1999-06-24
WO1999028745A1 (en) 1999-06-10
JP2001525186A (ja) 2001-12-11
CA2311705A1 (en) 1999-06-10
IL136392A0 (en) 2001-06-14
CA2311896A1 (en) 1999-06-24
DE69822510T2 (de) 2005-03-24
GB2338711B (en) 2000-11-15

Similar Documents

Publication Publication Date Title
ATE269974T1 (de) Identifizierung und charakterisierung von interagierenden molekülen mittels automatisierter interagierender paarung
DK0988534T3 (da) Elektroniske fremgangsmåder og apparat til detektering af analytter
DE60030281D1 (de) Methoden zur verbesserung der sensitivität und spezifität von screeningverfahren für krebs und krebs-vorstufen
DE69612017D1 (de) Emulsion zur robusten erfassung von gasen
DE69534629D1 (de) Derivate von zinkfingerproteinen und methoden
DE60041452D1 (de) CpG REZEPTOR (CpG-R) UND DARAUF BEZOGENE METHODEN
DE60030145D1 (de) Nachweisverfahren für kurze sequenzvarianten
DK0698093T3 (da) Von Hippel-Lindau-(VHL)-sygdomsgen og tilsvarende cDNA og metoder til påvisning af bærere af VHL-sygdomsgenet
ATE317451T1 (de) Verfahren zur diagnose, erkennung, und einstufung von dickdarmkrebs
WO1997012039A3 (en) Sh2-containing inositol-phosphatase
WO1999030165A3 (en) Processes for identifying a solvent condition suitable for determining a biophysical property of a protein
WO2001038566A3 (en) Screening method for candidate drugs
WO2003102015A3 (en) Method and apparatus for detecting and monitoring peptides, and peptides identified therewith
DE50007140D1 (de) Vorrichtung zur entnahme von schlackenproben
ATE284955T1 (de) Map-kinase: polypeptide, polynukleotide und ihre verwendung
ATE377094T1 (de) Detektion von wechselwirkungen auf sonden-arrays
CA2244654A1 (en) Use of annexins as a lupus anticoagulant control or standard in clotting tests
DE68919387D1 (de) DNS- und RNS-Proben, Methoden und Testsätze zum Nachweis von Salmonella.
DE69637724D1 (de) Polypeptide mit spezieller, funktioneller domäne, verfahren zu ihrer identifikation und anwendungen derselben
DE60025380D1 (de) Ein-schritttest zum nachweis von antimikrobiellen rückständen in eiern
DE60028374D1 (de) Verfahren und apparatur zum präsentieren von daten von thrombose- und haemostaseassays
EA200400024A1 (ru) Новый сцинтилляционный анализ близкого расстояния для изучения связывающих аминогликозид молекул (abm)
DE69806107T2 (de) Methoden und reagenzien zur regulierung von apoptosis
WO1999038975A3 (en) Polynucleotide and polypeptide sequences associated with cns depressant sensitivity and methods of use thereof
ATE278943T1 (de) Vorrichtung zur entnahme von schlackenproben

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties